NRC Health Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NRC Health stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $139.00K, a 5.30% increase year-over-year.
- NRC Health stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $132.00K, a 92.47% decline year-over-year.
- NRC Health stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $1.75M, a 484.00% increase year-over-year.
- NRC Health stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $284.00K.
- NRC Health stock issued during period, value, stock options exercised for fiscal 2025 was $320.00K, a 81.74% decline from fiscal 2024.
- NRC Health stock issued during period, value, stock options exercised for fiscal 2024 was $1.75M, a 4.00% decline from fiscal 2023.
- NRC Health stock issued during period, value, stock options exercised for fiscal 2023 was $1.82M, a 486.82% increase from fiscal 2022.
- NRC Health stock issued during period, value, stock options exercised for fiscal 2022 was $311.00K, a 79.73% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $139.00K 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $320.00K 10-K · filed 2026-03-05 | |
| 2025-03-31 | $132.00K 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $1.75M 10-K · filed 2026-03-05 | |
| 2024-03-31 | $1.75M 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $1.82M 10-K · filed 2026-03-05 | |
| 2023-06-30 | $284.00K 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $300.00K 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $311.00K 10-K · filed 2025-03-17 | |
| 2022-09-30 | $310.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $1.53M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $142.00K 10-Q · filed 2022-11-04 | |
| 2021-03-31 | $911.00K 10-Q · filed 2022-11-04 | |
| 2020-12-31 | $8.95M 10-K · filed 2023-03-03 | |
| 2020-09-30 | $1.97M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $2.04M 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $3.15M 10-Q · filed 2021-11-05 | |
| 2019-12-31 | $3.62M 10-K · filed 2022-03-04 | |
| 2019-09-30 | $1.52M 10-Q · filed 2020-11-06 | $2.96M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | $137.00K 10-Q · filed 2020-11-06 | $1.95M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | $633.00K 10-Q · filed 2020-11-06 | $5.99M derived: sum of 4 quarters · filed 2021-03-05 |
| 2018-12-31 | $669.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $6.10M 10-K · filed 2021-03-05 |
| 2018-09-30 | $510.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $4.18M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $737.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $2.46M 10-K · filed 2020-03-06 | |
| 2016-12-31 | $945.00K 10-K · filed 2019-03-08 | |
| 2015-12-31 | $406.00K 10-K · filed 2018-03-14 | |
| 2014-12-31 | $1.31M 10-K · filed 2017-03-03 | |
| 2013-12-31 | $990.00K 10-K · filed 2016-03-04 | |
| 2012-12-31 | $5.97M 10-K · filed 2015-03-04 | |
| 2011-12-31 | $940.00K 10-K · filed 2014-03-04 | |
| 2010-12-31 | $274.00K 10-K · filed 2013-03-01 | |
| 2009-12-31 | $18.00K 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |